All
Patient/physician teamwork produces best rejuvenation outcomes
October 21st 2005Chicago — The trend toward non-invasive rejuvenation of the face is continually expanding with methods ranging from the simplest at-home therapies to aggressive, high-tech methods of removing as many signs of aging as possible.
Reloxin effects comparable to Botox
October 21st 2005Europe's version of Botox, Dysport (Ibsen-Biotech Laboratories) is poised to officially cross the Atlantic, mainly into the offices of U.S. cosmetic surgeons, once Food and Drug Administration (FDA) approval is obtained by its U.S. marketer, Santa Barbara, Calif.-based Inamed.
Botulinum toxin popularity surges; non-cosmetic applications emerging
October 21st 2005Chicago — The popularity of botulinum toxin type A injections for correcting wrinkles of the upper face has increased dramatically over the past few years. The extent of its popularity as a cosmetic procedure is obvious when this statistic is considered: The number of botulinum toxin type A procedures rose 157 percent from 2002 to 2003; the next highest increase was chemical peels, which rose a relatively sparse 48 percent over that same period.
Combining products benefits soft tissue augmentation
October 21st 2005In Dr. Baumann's experience, Sculptra is safe and effective for off-label cosmetic use alone or in combination with other fillers. The nature of the product makes it suitable not just for filling wrinkles, but for changing the structure of the face.
Targeting psoriatic plaques with a single, high dose of UVB yields favorable outcomes
October 21st 2005St. Louis — Turbo UVB phototherapy with the 308 nm excimer laser performed using a single high dose appears to be a well-tolerated and rapidly effective method for treating chronic plaque psoriasis, according to the results of an open-label pilot trial undertaken by dermatologists at Case Western Reserve University, Cleveland.
Anti-TNF-alpha agents OK in pregnancy
October 21st 2005National report — Preliminary review finds no adverse effects of anti-TNF-alpha agents on pregnancy outcomes. Analyses of limited data collected by the Organization of Teratology Information Services (OTIS) suggest there is no increased risk of major malformations or spontaneous abortions in women who received treatment with an anti-TNF-alpha medication early during pregnancy, reports Christina Chambers, Ph.D., M.P.H., who is current President of OTIS, assistant professor, departments of pediatrics and family and preventive medicine, University of California San Diego, La Jolla, Calif.
Arden, Allergan team-up to market 'new' Prevage
October 4th 2005New York - In what is believed to be the first product collaboration between a cosmetics company and a drug, Elizabeth Arden Inc. and Allergan Inc., the pharmaceutical firm that markets and distributes Botox, have teamed up to market a reformulated version of Allergan's anti-aging product, Prevage.
Offer systemic therapy as first-line defense
September 1st 2005Buenos Aires — In selecting therapies for patients with psoriasis, dermatologists need to consider that psoriasis is a life-long, systemic disease that substantially affects a patient's quality of life, according to Alan Menter, M.D., chief of the division of dermatology at Baylor University Medical Center, Dallas.
Autologous cellular treatments show long-term results with contour defects
September 1st 2005Baltimore - Results of an exploratory phase 3 clinical trial demonstrate that injection of autologous living skin fibroblasts provides safe and effective correction of facial contour deformities that is sustained for at least 12 months, reports Robert A. Weiss, M.D.
Rejuvenating the face: New trends emerge
September 1st 2005National report - Even as new techniques, devices and pharmaceutical developments for facial contouring and wrinkle refinement proliferate for dermatologists and cosmetic surgeons, two trends are gaining momentum - one for the better and one for the worse, according to dermatologist David H. McDaniel, M.D., and his colleague, cosmetic surgeon Kyle S. Choe, M.D.